Related Experiment Video
Updated: Feb 9, 2026

Assessment of Stress Effects on Cognitive Flexibility using an Operant Strategy Shifting Paradigm
Published on: May 4, 2020
Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms
Megan B Barnet1,2,3, Wendy A Cooper4,5,6, Michael J Boyer7,8
1The Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia. m.barnet@garvan.org.au.
Abstract:
Immune checkpoint inhibitors have shown efficacy in the treatment of non-small cell lung cancer (NSCLC) in the adjuvant, first- and subsequent-line settings. In metastatic disease, they provide hope of durable response where “best-case” scenario has long been inadequate. This progress has highlighted the immunogenic nature of NSCLC and invigorated research into immunotherapy in the field. In this review we consider the foundations of immunotherapy in NSCLC, canvass the current research and summarise the evidence guiding clinical practice.
Related Concept Videos
Tumor Immunotherapy
Lung Capacity
Proton (¹H) NMR: Chemical Shift
Absorption signals of all the protium nuclei...
NMR Spectroscopy: Chemical Shift Overview
For instance, the proton...
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

